Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Cited In for PubMed (Select 15731171)

1.
2.

Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms.

Wang D, Lu J, Tindall DJ.

Cancer Lett. 2013 Jul 10;335(1):136-44. doi: 10.1016/j.canlet.2013.02.001. Epub 2013 Feb 9.

3.

Loss of the androgen receptor cofactor p44/WDR77 induces astrogliosis.

Vincent B, Wu H, Gao S, Wang Z.

Mol Cell Biol. 2012 Sep;32(17):3500-12. doi: 10.1128/MCB.00298-12. Epub 2012 Jul 2.

4.

Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy.

McCourt C, Maxwell P, Mazzucchelli R, Montironi R, Scarpelli M, Salto-Tellez M, O'Sullivan JM, Longley DB, Waugh DJ.

Clin Cancer Res. 2012 Jul 15;18(14):3822-33. doi: 10.1158/1078-0432.CCR-11-3277. Epub 2012 May 23.

5.

Nuclear transport signals control cellular localization and function of androgen receptor cofactor p44/WDR77.

Gu Z, Zhou L, Gao S, Wang Z.

PLoS One. 2011;6(7):e22395. doi: 10.1371/journal.pone.0022395. Epub 2011 Jul 15.

6.

TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable.

Davis JS, Nastiuk KL, Krolewski JJ.

Mol Endocrinol. 2011 Apr;25(4):611-20. doi: 10.1210/me.2010-0312. Epub 2011 Feb 3.

7.

Altered differentiation and proliferation of prostate epithelium in mice lacking the androgen receptor cofactor p44/WDR77.

Gao S, Wu H, Wang F, Wang Z.

Endocrinology. 2010 Aug;151(8):3941-53. doi: 10.1210/en.2009-1080. Epub 2010 Jun 2.

8.

beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Gluschnaider U, Hidas G, Cojocaru G, Yutkin V, Ben-Neriah Y, Pikarsky E.

PLoS One. 2010 Feb 5;5(2):e9060. doi: 10.1371/journal.pone.0009060.

10.

Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA.

Wang L, Zou X, Berger AD, Twiss C, Peng Y, Li Y, Chiu J, Guo H, Satagopan J, Wilton A, Gerald W, Basch R, Wang Z, Osman I, Lee P.

Am J Transl Res. 2009;1(1):62-71. Epub 2009 Jan 1.

11.

LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.

Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A, Garabedian MJ, Ferrari A, Lee P.

Cancer Res. 2009 Apr 15;69(8):3332-8. doi: 10.1158/0008-5472.CAN-08-3380. Epub 2009 Apr 7.

12.

Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.

Ganapathy M, Ghosh R, Jianping X, Zhang X, Bedolla R, Schoolfield J, Yeh IT, Troyer DA, Olumi AF, Kumar AP.

Clin Cancer Res. 2009 Mar 1;15(5):1601-11. doi: 10.1158/1078-0432.CCR-08-1389. Epub 2009 Feb 17.

13.

Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells.

Zhang X, Huang X, Olumi AF.

Int J Cancer. 2009 Apr 15;124(8):1980-9. doi: 10.1002/ijc.24139.

14.

Decoy receptor 3 is a prognostic factor in renal cell cancer.

Macher-Goeppinger S, Aulmann S, Wagener N, Funke B, Tagscherer KE, Haferkamp A, Hohenfellner M, Kim S, Autschbach F, Schirmacher P, Roth W.

Neoplasia. 2008 Oct;10(10):1049-56.

15.

Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.

Raclaw KA, Heemers HV, Kidd EM, Dehm SM, Tindall DJ.

Prostate. 2008 Nov 1;68(15):1696-706. doi: 10.1002/pros.20844.

16.

c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells.

Zhang X, Zhang L, Yang H, Huang X, Otu H, Libermann TA, DeWolf WC, Khosravi-Far R, Olumi AF.

Cancer Res. 2007 Oct 1;67(19):9425-34.

17.

A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression.

Qi W, Wu H, Yang L, Boyd DD, Wang Z.

EMBO J. 2007 Jan 10;26(1):65-75. Epub 2006 Dec 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk